You should NOT spray it directly in your eyes. Does the FDA recall of Chantix apply to Tyrvaya? In 2021, Pfizer recalled all their Chantix tablets due to the presence of N-nitroso-varenicline ...
product recalls, withdrawals and other unusual items; domestic and foreign health care and cost containment reforms, including government pricing, tax and reimbursement policies; technological ...
Pfizer is learning there is a kernel of truth in the saying “the internet never forgets.” More than three years after the ...
Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its ...
Pfizer's pipeline already includes two obesity drugs. However, doubts about Pfizer's lead obesity program could make buying Viking a smart move. The best bet is that Pfizer will wait for ...
The stock market is at record levels these days, but one company that isn't reflecting that optimism is Pfizer (NYSE: PFE). Shares of the pharma giant are down 28% over the past 12 months as ...
Pfizer believes the answer to its sliding valuation lies in oncology. The company, which is coming off one of the worst years in its history, unveiled on Thursday a new business unit dedicated to ...
Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo has shown its staying power in older adults who received a single dose before the previous virus season. In season two, Abrysvo was 78% ...
Pfizer aims to increase the proportion of biologic drugs in its oncology pipeline from 6% to 65% by 2030. Pfizer unveiled a dedicated oncology unit, leveraging Pfizer and Seagen's combined ...
Pfizer announced Thursday that its vaccine for RSV, or respiratory syncytial virus, protects older adults for more than two seasons, according to a late-stage clinical trial. Pfizer announced that ...
Pharma giant Pfizer, fresh off its $43 billion acquisition of Seagen, said it will shut down construction on a new 270,000 square-foot manufacturing facility Seagen was building north of Seattle ...
Eli Lilly is hot on Novo Nordisk's heels with its new obesity drug Zepbound. Pfizer (NYSE: PFE) remains on the outside ...